TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 48 filers reported holding TFF PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $296,409 | -26.1% | 846,884 | -0.8% | 0.00% | – |
Q2 2023 | $401,221 | -31.9% | 853,663 | -0.7% | 0.00% | – |
Q1 2023 | $588,980 | -34.7% | 859,449 | 0.0% | 0.00% | – |
Q4 2022 | $902,422 | -74.4% | 859,449 | -1.0% | 0.00% | – |
Q3 2022 | $3,526,000 | -28.1% | 868,431 | 0.0% | 0.00% | – |
Q2 2022 | $4,907,000 | -10.1% | 868,431 | +0.4% | 0.00% | – |
Q1 2022 | $5,458,000 | -24.2% | 864,983 | +6.5% | 0.00% | – |
Q4 2021 | $7,203,000 | +17.4% | 812,170 | +2.2% | 0.00% | – |
Q3 2021 | $6,138,000 | -17.2% | 795,038 | +3.0% | 0.00% | – |
Q2 2021 | $7,417,000 | -21.6% | 771,854 | +10.8% | 0.00% | – |
Q1 2021 | $9,457,000 | +5.4% | 696,907 | +11.2% | 0.00% | – |
Q4 2020 | $8,975,000 | +47.5% | 626,770 | +90.2% | 0.00% | – |
Q3 2020 | $6,086,000 | +1562.8% | 329,531 | +418.3% | 0.00% | – |
Q2 2020 | $366,000 | +50.0% | 63,584 | 0.0% | 0.00% | – |
Q1 2020 | $244,000 | -12.2% | 63,584 | +22.2% | 0.00% | – |
Q4 2019 | $278,000 | – | 52,031 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corriente Advisors, LLC | 1,058,823 | $19,556,000 | 9.92% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 220,666 | $4,076,000 | 4.24% |
Mesirow Financial Investment Management, Inc. | 34,902 | $645,000 | 2.76% |
Gagnon Advisors, LLC | 176,471 | $3,259,000 | 2.00% |
Nantahala Capital Management | 2,032,988 | $37,549,000 | 1.15% |
PRECEPT MANAGEMENT LLC | 235,294 | $4,346,000 | 1.07% |
GAGNON SECURITIES LLC | 219,584 | $4,056,000 | 0.86% |
Sepio Capital, LP | 84,560 | $1,562,000 | 0.17% |
683 Capital Management, LLC | 117,647 | $2,173,000 | 0.16% |
SANDERS MORRIS HARRIS LLC | 21,326 | $340,000 | 0.09% |